![](/img/cover-not-exists.png)
CASE MATCH CONTROL ANALYSIS OF PROPEL REVEALS A SURVIVAL ADVANTAGE FOR PATIENTS WITH RELAPSED PTCL RECEIVING PRALATREXATE: A NOVEL APPROACH TO BENCHMARK DRUGS IN RARE DISEASES
O'Connor, O.A., Marchi, E., Kim, W.S.Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2438_113
Date:
June, 2017
File:
PDF, 66 KB
english, 2017